Aarti Drugs has nearly completed its Rs. 600 Cr capex, bringing new plants (Salicylic Acid, Sayakha greenfield) online, driving capacity growth and market expansion.

Aarti Drugs LimitedAARTIDRUGS · Filed with the exchange

Q1 FY26 revenue rose 6% to Rs. 591 Cr, with PAT up 63% to Rs. 54 Cr, signaling a strong rebound after FY25's slight dip.

No comments yet. Be the first.

More from Aarti Drugs Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.